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1. Introduction
  Schistosomiasis remains as a major public health 
problem in the world. More than 600 million people in 
74 countries in the tropical areas are under the risk of 
infection. Approximately 200 million people are infected 
currently, and 120 million are symptomatic[1]. Potential 
vaccine strategies against schistosomiasis continue to be 
investigated and public health measures can be important 
for reducing incidence of the disease[2]. The treatment of 
schistosomiasis remains dependent on chemotherapeutic 
intervention, particularly with praziquantel (PZQ), the 
key drug for chemotherapy since 1980s[3]. But the major 
weakness of PZQ, lack in efficacy against juvenile 
schistosoma can cause rapid re-infection after treatment[4]. 
Some direct epidemic evidences on resistance or low 
sensitivity to PZQ had been reported[5-7]. These reports 
made scientists to find out new drugs to prevent and cure 
schistosomiasis.    
  In 1980’s, antischistosomal properties of the artemisinin 
and its derivatives (artemether, artesunate, etc), key drugs 
of antimalaria especially to multidrug resistant malaria, 
was discovered by Chinese scientists[8]. Since then, notable 
progress has been made in antischistosoma studies with 
artemether and artesunate[9-13]. Because artimisinins were 
efficacy to the juvenile stages of the schistosomes, which 
overcome the weakness of PQZ, that makes artemther and 
artesunate to be the chemoprophylactic drugs against 
schistosomiasis.
  The antischistosome mechanism of artemisinins has not 
yet been elucidated. The most striking biochemical changes 
measured in the schistosomes collected from infected 
mice treated with artemether were the reductions in their 
glycogen content and almost all glycolytic enzymes were 
inhibited different extent[14,15]. Lactate dehydrogenase 
in schistosomes was also reduced substantially after 
artemether administration[15]. It implied that glycolysis 
pathway or glycolytic enzymes might be the target(s) of 
artemisinins. Other works proved that hemin or Fe plays an 
important role in the action of the artimisinins in vitro[16-18]. 
  In our previous work, lactate dehydrogenase from 
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Schistosome japonicum (SjLDH) was cloned and expressed 
in Escherichia coli (E. coli), the enzymatic characterization 
of the recombinant SjLDH (rSjLDH) was described[19]. In this 
study, we focus on the effect of artemether, hemin and Fe3+ 
on the rSjLDH. 
 
2. Materials and methods 
2.1. Preparation of the stock solution 
  Artemether (Kunming Pharma. Corp., China) was dissolved 
in DMSO, then used Hank’s solution to prepare 5 mM stock 
solution. The stock solution was serially diluted with the 
Hank’s solution to make various concentrations of 0.02, 
0.04, 0.06, 0.08 and 0.10 mM. Same concentration of DMSO in 
Hank’s solution used as a control (DMSO in reaction system 
was not exceeded 0.1%).
  Hemin (Guangzhou Whiga Technology Co., Ltd, China) 
was dissolved in 5 mM NaOH solution to prepare 5 mM 
stock solution. Hemin was examined at concentration of 
0.002, 0.004, 0.006, 0.008, 0.010, 0.015 and 0.020 mM. Five mM 
NaOH was used as control.
  Fe3+ (FeCl3, Guangzhou Chemical Reagent Factory, China) 
was dissolved in distilled water to prepare 5 mM stock 
solution and examined at concentration of 0.10, 0.20, 0.30, 
0.40 and 0.50 mM. Distilled water was used as control. 
2.2. Preparation of rSjLDH and enzymatic assay for the effect 
of reagents on rSjLDH
  rSjLDH  preparation and enzymatic assay for the effect 
of the reagents on rSjLDH were performed by the methods 
described before[19]. Various concentrations of reagents 
were added in the standard system. The reaction was 
started by addition of enzyme and incubated at 37 曟 by 
following changes in optical density at 340 nm, ε=6.22 mM-
1cm-1. Enzymatic activity was measured with a DU530 DNA/
Protein Analyzer (Beckman, USA) for 1 min after starting the 
reaction. Each reaction was done for 3 times.
2.3. Statistical analyses
  Arithmetic mean and standard error(mean依SE)of the 
changes in optical density at 340 nm (△OD) of each reaction 
and the significance of drug influence (student t test) on 
LDH activity were computed using the SPSS13.0 statistical 
software. Relative enzymatic activity (%) of drug or control 
group was computed used that of the blank group as 100%, 
figures were formed by OriginPro 7.5SR1 software.
 
3. Results
3.1. Effect of artemether on rSjLDH
  The effect of artemether on reversible reaction catalyzed 
by rSjLDH was shown in Table 1 and Figure 1. Compared 
with that of the control, at concentration 0.02-0.10 mM of 
artemether, inhibitions of pyruvate reduction and lactate 
oxidation reaction were not observed.
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Figure 1. Effect of artemether on pyruvate reduction and lactate 
oxidation reaction catalyzed by rSjLDH. 
△: Reduction Reaction; ○: Oxidation Reaction; ―: PZQ; ┄: 
Control.
3.2. Effect of hemin on rSjLDH
  The effect of hemin on reversible reaction catalyzed 
by rSjLDH was shown in Table 2 and Figure 2. Obivious 
inhibition for lactate oxidation reaction and pyruvate 
reduction reaction were detected at 0.002 mM and 0.004 mM 
of hemin respectively, compared with that of the control 
(P<0.05). The relative enzymatic activity inhibitions for 
pyruvate reduction reaction and lactate oxidation reaction 
at 0.02 mM hemin were 93.48% and 100.00%, respectively, 
compared with that of control (P<0.01). 
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Figure 2. Effect of hemin on pyruvate reduction and lactate oxidation 
reaction catalyzed by rSjLDH.
 △: Reduction Reaction; ○: Oxidation Reaction; ―: PZQ; ┄: 
Control.
3.3. Effect of Fe3+ on rSjLDH
  The effect of Fe3+ on rSjLDH was shown in Figure 3 and 
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Table 3. Obvious inhibition for oxidation reaction and 
reduction reaction were observed at 0.1mM and 0.2mM, 
respectively, compared that of the control (P<0.05). The 
enzymatic activities for both reaction were completely 
inhibited by 0.5 mM Fe3+, compared with that of the control 
(P<0.01).  
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Figure 3. Effect of Fe3+ on pyruvate reduction and lactate oxidation 
reaction catalyzed by rSjLDH.
 △: Reduction Reaction; ○: Oxidation Reaction; ―: PZQ; ┄: 
Control.
4. Discussion
  It is known that parasitic stages of schistosoma largely 
depend on anaerobic energy metabolism[20]. Glycolysis 
is essential for the survival of the parasite and glycolytic 
enzymes appear to be potential targets for chemotherapeutic 
attacks. LDH is a terminal glycolytic enzyme, which 
catalyzes the interconversion reaction of pyruvate and lactate 
in the presence of the nicotinamide adenine dinucleotide 
coenzyme. Studies on LDH from plasmodium(pLDH) and 
Toxoplasma gondii (LDH1, LDH2) had shown that they have 
distinct properties from that of the hosts and appear to be 
an attractive target for therapy[21,22]. Works on artemether 
were reported that it can inhibit the activity of the most 
glycolytic enzymes include LDH in schistosomes collected 
from artemether-treated mice[23]. These implied that these 
enzymes may serve as the targets of artemther. 
  About the mechanism of the artemether on schistosomes, 
scientists presumed that it might be similar to that of for 
malaria[8]. Artemisinins are activated within the parasites by 
intraparasitic heme-iron or other iron system, which results 
in the cleavage of the endoperoxide bridges and generation 
of free radicals. These free radicals then may form covalent 
bounds with specific proteins or receptors and kill the 
parasites[24]. 
Table 1
Effect of artemether on rSjLDH.
Reaction group △OD/min of the enzymatic reaction at each drug concentration
0 mM 0.02 mM 0.04 mM 0.06 mM 0.08 mM 0.1 mM
R 
Art
0.111依0.007
0.101依0.006 0.089依0.006 0.099依0.004 0.090依0.014 0.094依0.008
Ctr 0.104依0.008 0.095依0.003 0.095依0.004 0.084依0.011 0.085依0.010
O
Art
0.108依0.003
0.092依0.009 0.095依0.014 0.098依0.003 0.097依0.001 0.089依0.005
Ctr 0.084依0.006 0.081依0.007 0.087依0.004 0.089依0.003 0.088依0.006
 R: Reduction reaction; O: Oxidation reaction; Art: artemether; Ctr: control (DMSO+Hank’s solution). Data presented in the table are means of 
three determinations依SE. 
Table 2
Effect of hemin on rSjLDH.    
Reaction group
△OD/min of the enzymatic reaction at each drug concentration
0 mM 0.002 mM 0.004 mM 0.06 mM 0.08 mM 0.01 mM 0.015 mM 0.02 mM
R
Hem
0.098依0.003
0.102依0.004 0.087依0.006☆ 0.075依0.003★ 0.060依0.006★ 0.051依0.004★ 0.006依0.010★ 0.026依0.010★
Ctr 0.097依0.008 0.102依0.006 0.106依0.005 0.101依0.008 0.101依0.007 0.092依0.018 0.106依0.005
O
Hem
0.121依0.006
0.090依0.006☆ 0.065依0.008★ 0.059依0.010★ 0.038依0.017★ 0.023依0.008★ 0 0
Ctr 0.118依0.007 0.108依0.005 0.109依0.006 0.113依0.006 0.106依0.004 0.116依0.006 0.109依0.007
R: Reduction reaction; O: Oxidation reaction; Hem: hemin; Ctr: control (5 mM NaOH). Data presented in the table are means of three 
determinations依SE; ☆:P<0.05; ★: P<0.01.  
Table 3
Effect of Fe3+ on rSjLDH.     
Reaction group
△OD/min of the enzymatic reaction at each drug concentration
0 mM 0.1 mM 0.2 mM 0.3 mM 0.4 mM 0.5 mM
R Fe3+ 0.067依0.009 0.052依0.004 0.023依0.008☆ 0.010依0.009★ 0.005依0.004★ 0.000依0.006★
Ctr 0.059依0.006 0.062依0.013 0.063依0.014 0.055依0.017 0.054依0.008
O Fe3+ 0.085依0.007 0.026依0.010☆ 0.023依0.009★ 0.016依0.012★ 0.001依0.006★ 0.000依0.009★
Ctr 0.082依0.007 0.084依0.100 0.089依0.006 0.092依0.007 0.087依0.005
 Fe3+: FeCl3; Ctr: control (Distilled water); R: Reduction reaction; O: Oxidation reaction; △OD/min is following change in optical density 1min 
after starting the reaction; data are the means of three determinations依SE. ☆:P<0.05; ★: P<0.01.
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  The data obtained in vitro and in vivo studies with 
schistiosomes described before showed that no effect on the 
worms was observed when schistosomes were exposured 
to media containing only artemether or hemin; cultivation 
of the parasites in the artemther plus hemin containing 
media obvious effect on the worms[25]; the activity of lactate 
dehydrogenase in schistosomes collected from artemether-
treated mice was inhibited substantially[15]. In the present 
work, no inhibition was observed on rSjLDH at 0.02-0.10 
mM of artemether, but significant inhibition was presented 
at 0.004-0.020 mM of hemin and 0.2-0.5mM of Fe3+. We 
can conclude that artemether or artemether plus hemin 
had no direct effect on SjLDH, the inhibition of the SjLDH 
by artemether observed in vivo might simply reflect non-
specific changes occurring during drug-induced parasite 
damage.  
  Interestingly, we observed that hemin and Fe3+ was reacted 
by SjLDH and also was inhibited their activities, especially 
hemin. Hemin is one of hemoglobin degrading product 
from schistosoma ingested red blood cell. Hemin is a strong 
oxidant and has cytotoxicity on cells of parasites or host. 
Ferrous Hb undergoes spontaneous oxidation to ferric 
iron-containing methemoglobin, which releases its heme 
groups more readily than ferrous Hb. Heme is broken down 
to biliverdin, Fe2+, and CO catalyzed by heme oxygenases 
(HO). And biliverdin is reduced to atoxic bilirubin by the 
biliverdin reductase then[26]. A complete degrading enzyme 
system of hemin was found in schistosoma. It is deduced 
that HO may play a key role in antischistosome mechanism 
of artemisinins.   
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